HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
COLLOSS E
bone void filler containing lypholized type I collagen and BMPs with ability to produce new bone in an ectopic location in rats
Networked:
1
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Macromolecular Substances: 97
Polymers: 13051
Biopolymers: 773
Collagen: 52417
COLLOSS E: 1
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Intercellular Signaling Peptides and Proteins: 29768
TGF-beta Superfamily Proteins: 1
Bone Morphogenetic Proteins: 1832
COLLOSS E: 1
Scleroproteins: 74
Extracellular Matrix Proteins: 3148
Collagen: 52417
COLLOSS E: 1
Peptides: 82426
Intercellular Signaling Peptides and Proteins: 29768
TGF-beta Superfamily Proteins: 1
Bone Morphogenetic Proteins: 1832
COLLOSS E: 1
Biological Factors: 2472
Intercellular Signaling Peptides and Proteins: 29768
TGF-beta Superfamily Proteins: 1
Bone Morphogenetic Proteins: 1832
COLLOSS E: 1
Experts
1.
Jansen, John A
: 1 article (06/2006)
2.
Merkx, Matthias A W
: 1 article (06/2006)
3.
Nienhuijs, Marloes E L
: 1 article (06/2006)
4.
Stoelinga, Paul J W
: 1 article (06/2006)
5.
Walboomers, X Frank
: 1 article (06/2006)
Related Diseases
1.
Infections
06/01/2006 - "
To overcome problems with risk of transmissable spongiform encephalopathy (TSE) infection, an equine derived version was investigated in this study, named COLLOSS E.
"
2.
Brain Diseases (Brain Disorder)
06/01/2006 - "
To overcome problems with risk of transmissable spongiform encephalopathy (TSE) infection, an equine derived version was investigated in this study, named COLLOSS E.
"